De novo monomorphic and polymorphic ventricular tachycardia following coronary artery bypass grafting - 10/09/11
Doi : 10.1016/S0002-9149(97)00287-7
Rabih R. Azar, MD, MS a, b, 1, Ellison Berns, MD a, b, Bonnie Seecharran, MD a, b, Joan Veronneau, RN a, b, Neal Lippman, MD a, b, Jeffrey Kluger, MD a, b
a From the Division of Cardiology, Hartford Hospital, Hartford, Connecticut, USA
b From the University of Connecticut School of Medicine, Hartford, Connecticut, USA
Abstract |
In conclusion, after CABG surgery, de novo monomorphic VT represents an underlying arrhythmogenic substrate and requires aggressive management, frequently with an internal cardiovertor defibrillator. Polymorphic VT is more likely related to transient perioperative abnormalities, although the possibility of an underlying electrophysiologic substrate cannot be ruled out in patients with significant ventricular dysfunction and a history of myocardial infarction; their care should be individualized and high-risk patients treated aggressively.
Le texte complet de cet article est disponible en PDF.© 1997
Publié par Elsevier Masson SAS.
Vol 80 - N° 1
P. 76-78 - juillet 1997 Retour au numéro
Article précédent
- Routine platelet transfusion in patients undergoing emergency coronary bypass surgery after receiving abciximab
- Craig P. Juergens, Alan C. Yeung, Stephen N. Oesterle
- Effect of fluvastatin on low-density lipoprotein peak particle diameter
- H.Robert Superko, Ronald M. Krauss, Connie DiRicco
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?